Intervention

A CDK4/6 inhibitor different from the first that the participant had received, plus fulvestrant.

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.NCT07227233 · 2026-03-31

RECRUITING

Common conditions

Breast Cancer1

Leading sponsors

University of California, San Diego1

Trial status mix

RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.